These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23254779)

  • 1. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.
    Grover M; Camilleri M
    J Gastroenterol; 2013 Feb; 48(2):177-81. PubMed ID: 23254779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.
    Chumpitazi BP; Kearns GL; Shulman RJ
    Aliment Pharmacol Ther; 2018 Mar; 47(6):738-752. PubMed ID: 29372567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin in the gastrointestinal tract.
    Camilleri M
    Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):53-9. PubMed ID: 19115522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.
    Chial HJ; Camilleri M; Burton D; Thomforde G; Olden KW; Stephens D
    Am J Physiol Gastrointest Liver Physiol; 2003 Jan; 284(1):G130-7. PubMed ID: 12488239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
    Shah E; Kim S; Chong K; Lembo A; Pimentel M
    Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial overview: serotonergic agents in functional GI disorders: targeting the brain-gut axis.
    Wessinger S; Jones MP; Crowell MD
    Curr Opin Investig Drugs; 2005 Jul; 6(7):663-6. PubMed ID: 16044660
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional dyspepsia and irritable bowel syndrome, are they different entities and does it matter?
    Gwee KA; Chua AS
    World J Gastroenterol; 2006 May; 12(17):2708-12. PubMed ID: 16718757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for functional gastrointestinal disorders in children.
    Chitkara DK; Di Lorenzo C
    Curr Opin Pharmacol; 2006 Dec; 6(6):536-40. PubMed ID: 16949871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serotonin signaling system: from basic understanding to drug development for functional GI disorders.
    Gershon MD; Tack J
    Gastroenterology; 2007 Jan; 132(1):397-414. PubMed ID: 17241888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs.
    Olden KW
    CNS Spectr; 2005 Nov; 10(11):891-6. PubMed ID: 16273017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.
    Mayer EA; Tillisch K; Bradesi S
    Aliment Pharmacol Ther; 2006 Sep; 24(6):919-33. PubMed ID: 16948804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional and motor gastrointestinal disorders].
    Mearin F; Rey E; Balboa A
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():3-12. PubMed ID: 26520191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin and its role in colonic function and in gastrointestinal disorders.
    Costedio MM; Hyman N; Mawe GM
    Dis Colon Rectum; 2007 Mar; 50(3):376-88. PubMed ID: 17195902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontiers in functional dyspepsia.
    Fajardo NR; Cremonini F; Talley NJ
    Curr Gastroenterol Rep; 2005 Aug; 7(4):289-96. PubMed ID: 16042912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents.
    Kaminski A; Kamper A; Thaler K; Chapman A; Gartlehner G
    Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD008013. PubMed ID: 21735420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communication between gastrointestinal bacteria and the nervous system.
    Bravo JA; Julio-Pieper M; Forsythe P; Kunze W; Dinan TG; Bienenstock J; Cryan JF
    Curr Opin Pharmacol; 2012 Dec; 12(6):667-72. PubMed ID: 23041079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of tegaserod on proximal gastric tone and on the perception of gastric distention in functional dyspepsia.
    Tack J; Janssen P; Bisschops R; Vos R; Phillips T; Tougas G
    Neurogastroenterol Motil; 2011 Feb; 23(2):e32-9. PubMed ID: 20979591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.